Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BMS1 pseudogene 4 (BMS1P4) is a human pseudogene, meaning it is a segment of DNA that resembles a gene but is generally non-functional and does not encode a protein. It is classified as a pseudogene because it has sequence similarity to the protein-coding BMS1 gene, which encodes a ribosome biogenesis factor involved in the synthesis of 40S ribosomal subunits, but BMS1P4 itself does not produce a functional protein product. It is not considered a receptor, enzyme, transporter, or other typical drug target, and there is no evidence of direct therapeutic relevance, biological function, or disease association described in current reference databases or literature[5][6]. No roles in disease, biomarker applications, known interacting drugs, or safety concerns are described for BMS1P4, as expected for most pseudogenes[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BMS1 pseudogene 4 (BMS1P4).